نبذة مختصرة : Objective: to characterize the sociodemographic, clinical and epidemiological profile of women with breast cancer treated with chemotherapy. Method: descriptive-exploratory study, with quantitative approach, developed at the university hospital with 195 women. There was collection of the information from the nursing notes form used in the nursing process, the medical records and the Hospital Information System (HIS). Data were entered in Excel spreadsheet, used the chi-square test, considering p < 0.05. Results: mean age 54.37 years; Caucasians (69.74%). Gynecological and obstetrical history: (43%) contraceptive use, (87.69%) had children; (15.9%) early menarche, (3.58%) late menopause. Living habits: high incidence of overweight and obesity (45.12%). The late menopause and obesity variables were statistically significant (p<0.011). There was a predominance of adjuvant treatment (59%); FAC chemotherapy regimen with (37.43%); staging levels: IIA (17.43%) and IIIB (17.43%). Conclusion: studies like this enable health actions planned at all levels of attention and thus promote better living conditions for the target populations. Descriptors: Breast Neoplasms; Risk Factors; Chemotherapy; Oncology Nursing. RESUMO Objetivo: caracterizar o perfil sociodemográfico, epidemiológico e clínico de mulheres com câncer de mama tratadas com quimioterapia. Método: estudo descritivo-exploratório, de natureza quantitativa, desenvolvido no hospital universitário com 195 mulheres. Foram coletadas informações do formulário de anotações de enfermagem utilizado no Processo de Enfermagem, dos prontuários e do Sistema de Informação Hospitalar (SIH). Os dados foram digitados em planilha do Excel, empregado o teste Qui-quadrado, considerando significância p < 0,05. Resultados: idade média 54,37 anos; raça branca (69,74%). História ginecológico-obstétrica: (43%) uso de anticoncepcional, (87,69%) tiveram filhos; (15,9%) menarca precoce, (3,58%) menopausa tardia. Hábitos de vida: elevada incidência de sobrepeso e obesidade ...
No Comments.